Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients

被引：2
|
作者：
Takezako, Naoki [1 ]
Tokuhira, Michihide [2 ]
Sekiguchi, Naohiro [1 ]
Kizaki, Masahiro [2 ]
机构：
[1] Disaster Med Ctr, Tachikawa, Tokyo, Japan
[2] Saitama Med Ctr, Saitama, Japan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.257
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-255
引用
收藏
页码：E142 / E143
页数：2
相关论文
共 50 条
  • [1] The Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients
    Takezako, Naoki
    Tokuhira, Michihide
    Sekiguchi, Naohiro
    Kurihara, Yuya
    Ito, Kenichi
    Kurimoto, Miwa
    Suzuki, Kenshi
    Kizaki, Masahiro
    BLOOD, 2016, 128 (22)
  • [2] Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
    Bringhen, Sara
    Larocca, Alessandra
    Rossi, Davide
    Cavalli, Maide
    Genuardi, Mariella
    Ria, Roberto
    Gentili, Silvia
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Rizzo, Vincenzo
    Cangialosi, Clotilde
    Musto, Pellegrino
    De Rosa, Luca
    Liberati, Anna Marina
    Grasso, Mariella
    Falcone, Antonietta P.
    Evangelista, Andrea
    Cavo, Michele
    Gaidano, Gianluca
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2010, 116 (23) : 4745 - 4753
  • [3] Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients.
    Bringhen, Sara
    Larocca, Alessandra
    Rossi, Davide
    Romano, Alessandra
    Genuardi, Mariella
    Ria, Roberto
    Leoni, Pietro
    Patriarca, Francesca
    Nozzoli, Chiara
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Gentilini, Fabiana
    Elice, Francesca
    Olivero, Barbara
    Grasso, Mariella
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Allegra, Alessandro
    Rizzo, Manuela
    Leonardi, Giovanna
    Oddolo, Daniela
    Morabito, Fortunato
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2010, 116 (21) : 1248 - 1249
  • [4] The Efficacy and Safety of Bortezomib and Dexamethasone as a Maintenance Therapy in Patients With Advanced Multiple Myeloma Who Are Responsive to Salvage Bortezomib-Containing Regimens
    Benevolo, Giulia
    Larocca, Alessandra
    Gentile, Massimo
    Pregno, Patrizia
    Gay, Francesca
    Botto, Barbara
    Frairia, Chiara
    Evangelista, Andrea
    Morabito, Fortunato
    Boccadoro, Mario
    Vitolo, Umberto
    Palumbo, Antonio
    CANCER, 2011, 117 (09) : 1884 - 1890
  • [5] Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment
    Morabito, Fortunato
    Gentile, Massimo
    Mazzone, Carla
    Rossi, Davide
    Di Raimondo, Francesco
    Bringhen, Sara
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Petrucci, Maria Teresa
    Benevolo, Giulia
    Vincelli, Iolanda
    Guglielmelli, Tommasina
    Grasso, Mariella
    Marasca, Roberto
    Baldini, Luca
    Montefusco, Vittorio
    Musto, Pellegrino
    Cascavilla, Nicola
    Majolino, Ignazio
    Musolino, Caterina
    Cavo, Michele
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2011, 118 (22) : 5759 - 5766
  • [6] BORTEZOMIB-BASED THERAPY IN FRAIL MULTIPLE MYELOMA PATIENTS
    Antonioli, E.
    Staderini, M.
    Nozzoli, C.
    Bacchiarri, F.
    Barone, F.
    Grieco, P.
    Coltro, G.
    Guarrera, A.
    Messeri, M.
    Bosi, A.
    HAEMATOLOGICA, 2017, 102 : 132 - 132
  • [7] EFFICACY AND SAFETY OF WEEKLY INFUSION BORTEZOMIB IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Bringhen, S.
    Genuardi, M.
    Rossi, D.
    Petrucci, M.
    Andriani, A.
    Rizzi, R.
    Mele, G.
    Aitoro, G.
    Mettivier, V.
    Annibali, O.
    Rossini, F.
    Gentilini, P.
    Pavone, V.
    Cellini, C.
    Giuliani, N.
    Rauco, A.
    Baraldi, A.
    Dominietto, A.
    Capaldi, A.
    Pescosta, N.
    Rizzi, R.
    Nozza, A.
    Spadano, A.
    De Stefano, V.
    Holanek, M.
    Gaidano, G.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 149 - 149
  • [8] Efficacy and safety of Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) versus Bortezomib, Melphalan, and Prednisone (VMP) in Chinese patients with newly diagnosed Multiple Myeloma: OCTANS
    Fu, Weijun
    Huang, Honghui
    Li, Wei
    An, Gang
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, Chor Sang
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Jia, Bin
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Hou, Jian
    Wang, Jianxiang
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S125 - S125
  • [9] Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
    Kristian T. Andersen
    Maja Hinge
    Agoston Gyula Szabo
    Erik Segel
    Tina Ormstrup
    Paw C. Holdgaard
    Niels Pallisgaard
    Gitte Kerndrup
    Torben Plesner
    Clinical Hematology International, 2020, 2 (1) : 35 - 39
  • [10] EFFICACY, SAFETY AND TOLERANCE OF BORTEZOMIB IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
    Ballina, B.
    Fuertes, M.
    Cerda, S.
    Martinez Robles, V
    Gonzalez, P.
    Rondon, F.
    Yacoubi, S.
    Rodriguez, J. A.
    Escalante, F.
    HAEMATOLOGICA, 2017, 102 : 94 - 95
12345